Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sun Pharmaceutical Industries has received a United States Foods and Drug Administration (US-FDA) approval for cholesterol drug Zetia generic that Glenmark Pharma had exclusivity on which they had received all the way back in December but that is not the only story for Sun. this is the second approval that they have received just in the past week from US-FDA.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Sudarshan Sukhani of s2analytics.com is of the view that one can avoid PSU banks and focus on NBFC and advises buying Infosys and LIC Housing Finnace.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying UPL, Max Financial Services and Glenmark Pharma.
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on the market and specific stocks.
In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18's Surabhi Upadhyay and Nigel D'souza, SP Tulsian shared his readings and outlook on the fundamentals of the market and specific stocks.
Acccording to Ashwani Gujral of ashwanigujral.com, Reliance Infrastructure may test Rs 635-640.
Asian Paints, HCL Tech and Glenmark Pharma, among others, are on the radar of analysts today.
According to Mitessh Thakkar of miteshthacker.com, one can buy Sun TV Network, ICICI Bank and Ahluwalia Contracts while one can sell Glenmark Pharma and Hindustan Petroleum Corporation.
In an interview to CNBC-TV18 technical analyst, Ashwani Gujral of ashwanigujral.com shared his reading and outlook on the market and also gave recommendations on various stocks.
Mitessh Thakkar of miteshthacker.com is of the view that one can sell Glenmark Pharma and JSPL and buy Avenue Supermarts.
In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on specific pharmaceutical stocks.
Rajat Bose of rajatkbose.com advises exiting Glenmark Pharma.
Mitessh Thakkar of mitesshthakkar.com is of the view that one may buy Glenmark Pharma and Muthoot Capital Services.
Sudarshan Sukhani of s2analytics.com is of the view that one can short Glenmark Pharma and Just Dial while can buy Dabur India, Apollo Tyres and Tata Chemicals.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Glenmark Pharma while buy BEML and Bharat Forge.
Prakash Gaba of prakashgaba.com is of the view that Bharat Heavy Electricals can climb to Rs 175 while Glenmark Pharma can test Rs 880.
In an interview to CNBC-TV18’s Latha Venkatesh, Anuj Singhal, and Sonia Shenoy, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.
Sudarshan Sukhani of s2analytics.com expects momentum in BoB and Canara Bank while advises selling Glenmark Pharma.